SN

Sri Niwas Tiwari

Active Director Director DIN 09473793
DIN 09473793 First appointment Feb 2022 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Sri Niwas Tiwari

Data last updated:

Sri Niwas Tiwari is a Director at Bidose Pharmaceuticals Private Limited (since 2022). The company operates in Chemicals.

DIN 09473793
Primary Designation Director
Industry Chemicals
First Appointment 01 Feb 2022
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Feb 20222021Active

Board colleagues of Sri Niwas Tiwari

NameDINCompanyDesignation
Preeti Pandey09380553Bidose Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Bidose Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sri Niwas Tiwari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sri Niwas Tiwari

Sri Niwas Tiwari currently holds 1 directorship: Bidose Pharmaceuticals Private Limited (Director, since 01 Feb 2022).

Sri Niwas Tiwari was first appointed on 01 Feb 2022 as Director at Bidose Pharmaceuticals Private Limited.

The current boards of Sri Niwas Tiwari's companies include Preeti Pandey (Bidose Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available